Загрузка...
Novel Treatments for Systemic Lupus Erythematosus
There are many new therapeutic directions for the disease systemic lupus erythematosus (SLE). Despite this, the US Food and Drug Administration (FDA) has approved only one biological agent and it involves B cells, now thought to play a significant role in the pathogenesis of SLE. The name of the dru...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3383530/ https://ncbi.nlm.nih.gov/pubmed/22870484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X11415456 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|